|
Market Closed -
NYSE
16:01:40 2026-11-11 EST
|
5-day change | 1st Jan Change | ||
| 29.45 USD | +0.31% |
|
-4.35% | +18.27% |
| 04:47am | Eli Lilly Gets China's Approval for Weight-Loss Pill; Shares Jump Pre-Bell | MT |
| 02:57am | China approves Eli Lilly's weight-loss pill | FW |
| Market Cap | 168B 151B 140B 126B 239B 15,744B 245B 1,675B 668B 8,432B 630B 617B 26,833B | P/E 2026 * |
18.3x | P/E 2027 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise Value | 216B 194B 180B 162B 307B 20,222B 315B 2,152B 858B 10,830B 809B 792B 34,465B | EV / Sales 2026 * |
3.42x | EV / Sales 2027 * | 3.4x |
| Free-Float |
59.05% | Yield 2026 * |
5.84% | Yield 2027 * | 5.89% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PFE | Delayed | |
CBOE
| PFE | Real-time | |
|
Tradegate
| PFE | Real-time | |
|
Xetra
| PFE | Delayed | |
|
Kazakhstan S.E.
| PFE_KZ | End-of-day quote | |
|
Boerse Muenchen
| PFE | Real-time | |
|
Mexican S.E.
| PFE * | End-of-day quote | |
|
Borsa Italiana
| 1PFE | End-of-day quote | |
|
Bulgaria S.E.
| PFE | End-of-day quote | |
|
Börse Stuttgart
| PFE | Delayed | |
|
CBOE
| PFEs | Real-time | |
|
London S.E.
| PFZ | Delayed | |
|
Deutsche Boerse AG
| PFE | Delayed | |
|
Wiener Boerse
| PFE | End-of-day quote | |
|
Bolsa De Valores De Colombia
| PFECO | End-of-day quote | |
|
Lima
| PFEUS | End-of-day quote | |
|
CBOE
| PFZ | Real-time | |
|
Santiago S.E.
| PFE | End-of-day quote | |
|
Santiago S.E.
| PFECL | End-of-day quote | |
|
Swiss Exchange
| PFE | Delayed | |
|
Swiss Exchange
| PFE | Delayed |
Last Transcript: Pfizer Inc.
| 1 day | +0.59% | ||
| 1 week | -4.35% | ||
| Current month | -3.51% | ||
| 1 month | +4.14% | ||
| 3 months | +10.63% | ||
| 6 months | +14.10% | ||
| Current year | +18.27% |
| 1 week | 28.54 |  | 29.63 |
| 1 month | 28.13 | | 31.44 |
| Current year | 23.62 | | 31.44 |
| 1 year | 23.62 | | 31.44 |
| 3 years | 20.92 | | 31.54 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
Cecile Guegan
DFI | Director of Finance/CFO | 55 | 2026-08-15 |
Rady Johnson
CMP | Compliance Officer | 65 | 2013-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/30/26 | Free | Chief Executive Officer | 20 | 0.0000% | ||
| 10/15/26 | Free | Chief Executive Officer | 20 | 0.0000% | ||
| 10/13/26 | Free | Chief Executive Officer | 71 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.31% | -4.35% | +15.44% | -0.10% | 168B | |
| +0.35% | +1.36% | +45.38% | +140.47% | 1,280B | |
| -0.13% | +1.48% | +44.67% | +90.43% | 675B | |
| +0.37% | +0.05% | +31.00% | +112.84% | 521B | |
| +0.71% | +3.55% | +39.67% | +69.88% | 386B | |
| -0.59% | -2.11% | +61.83% | +45.16% | 363B | |
| +1.12% | +0.30% | +28.48% | +58.97% | 301B | |
| +0.73% | -0.03% | +3.85% | +36.98% | 286B | |
| +0.62% | -2.17% | +38.31% | +75.12% | 253B | |
| -0.67% | -2.72% | +38.49% | +123.56% | 211B | |
| Average | +0.61% | -0.68% | +34.71% | +75.33% | 444B | |
| Weighted average by Cap. | +0.89% | +0.11% | +38.75% | +93.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.13B 56.9B 52.57B 47.52B 89.9B 5,921B 92.12B 630B 251B 3,171B 237B 232B 10,091B | 60.82B 54.82B 50.64B 45.78B 86.62B 5,704B 88.76B 607B 242B 3,055B 228B 223B 9,722B |
| Net income | 8.56B 7.72B 7.13B 6.45B 12.2B 803B 12.5B 85.47B 34.07B 430B 32.14B 31.46B 1,369B | 11.69B 10.54B 9.73B 8.8B 16.65B 1,096B 17.06B 117B 46.5B 587B 43.87B 42.94B 1,869B |
| Net Debt | 47.74B 43.03B 39.76B 35.94B 67.99B 4,478B 69.67B 476B 190B 2,398B 179B 175B 7,632B | 39.17B 35.3B 32.61B 29.48B 55.78B 3,674B 57.16B 391B 156B 1,967B 147B 144B 6,261B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-11 | US$29.45 | +0.31% | 26,027,922 |
| 26-11-10 | US$29.36 | +0.44% | 31,128,745 |
| 26-11-09 | US$29.23 | -0.54% | 45,770,041 |
| 26-11-06 | US$29.39 | -1.64% | 48,319,585 |
| 26-11-05 | US$29.88 | -2.96% | 53,051,021 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
